Pharma Talks with Nataliya Andreychuk | Live from Reuters Barcelona | Haider Alleg

In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Haider Alleg, pharma strategist turned venture capitalist at Allegory Capital, to explore why AI in pharma commercial operations is still mostly noise — and what it will actually take to change that.With 20 years in pharma and a fresh perspective from the VC world, Haider cuts through the hype and makes a bold claim: this isn't a technology shift. It's a culture shift.Key takeaways:AI in R&D and manufacturing is already mature — commercial operations are just catching upDark factories and agentic systems show what full automation can look likeThe biggest opportunity isn't automating tasks — it's re-internalizing operational work with AIMedical and scientific affairs are best positioned to lead the way right nowThe advice that matters most: get your hands dirty and stay curious📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)🔗 Follow & Connect:🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/🎙️ Haider Alleg → https://www.linkedin.com/in/haideralleg/